Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]
Authors
Andrea J. Sterkenburg (ORCID: https://orcid.org/0000-0002-6147-650X)
Jos M.A. Kuijlen (ORCID: https://orcid.org/0000-0002-2907-5853)
J. Marc C. van Dijk (ORCID: https://orcid.org/0000-0002-0814-5680)
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]
Andrea J. Sterkenburg, Jos M.A. Kuijlen, J. Marc C. van Dijk, Wouter Bastiaan Nagengast et al.
Citations
6 citations
Journal
European Journal of Nuclear Medicine and Molecular Imaging
Topics
Pituitary Gland Disorders and Treatments
Field-Weighted Citation Impact (FWCI)
2.15
article
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]
Andrea J. Sterkenburg, Jos M.A. Kuijlen, J. Marc C. van Dijk, Wouter Bastiaan Nagengast, Iris Schmidt, Rob A. Vergeer, Schelto Kruijff, Astrid G. W. Korsten‐Meijer, Gerrit van den Berg, Wilfred F.A. den Dunnen, André P. van Beek, Dominic J. Robinson, Robert A. Feijen, Mark R Postma
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Nuclear Medicine and Molecular ImagingVol. 52(2)
Institutions
University Medical Center Groningen (NL), University of Groningen (NL), Erasmus MC Cancer Institute (NL)